Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-Ornithine L-Aspartate in Overt Hepatic Encephalopathy
NCT00433368Phase 3Completed
- Sponsor
- Aga Khan University
- Start
- Oct 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of l-ornithine l-aspartate in hepatic encephalopathy (HE), sponsored by Aga Khan University. Started Oct 2003; status: completed.
02
Drugs
l-ornithine l-aspartate
03
Conditions
hepatic encephalopathy (HE)
Beyond the preview
Go deeper on NCT00433368.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00433368.